Antithrombotic Therapy for Patients With Atrial Fibrillation and Bioprosthetic Valves　― Real-World Data From the Multicenter, Prospective, Observational BPV-AF Registry ―-Reference-Cited by-同舟云学术

Antithrombotic Therapy for Patients With Atrial Fibrillation and Bioprosthetic Valves　― Real-World Data From the Multicenter, Prospective, Observational BPV-AF Registry ―

Published:2021-10-29 Issue: Volume: Page:
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Izumi Chisato¹,Miyake Makoto²,Fujita Tomoyuki³,Koyama Tadaaki⁴,Tanaka Hidekazu⁵,Ando Kenji⁶,Komiya Tatsuhiko⁷,Izumo Masaki⁸,Kawai Hiroya⁹,Eishi Kiyoyuki¹⁰,Yoshida Kiyoshi¹¹,Kimura Takeshi¹²,Nawada Ryuzo¹³,Sakamoto Tomohiro¹⁴,Shibata Yoshisato¹⁵,Fukui Toshihiro¹⁶,Minatoya Kenji¹⁷,Tsujita Kenichi¹⁸,Sakata Yasushi¹⁹,Takegami Misa²⁰,Kimura Tetsuya²¹,Sugio Kumiko²¹,Takita Atsushi²²,Nishimura Kunihiro²⁰,Furukawa Yutaka²³,

Affiliation:

1. Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center

2. Department of Cardiology, Tenri Hospital

3. Cardiovascular Surgery Department, National Cerebral and Cardiovascular Center

4. Department of Cardiovascular Surgery, Kobe City Medical Center General Hospital

5. Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine

6. Department of Cardiology, Kokura Memorial Hospital

7. Department of Cardiovascular Surgery, Kurashiki Central Hospital

8. Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine

9. Department of Cardiology, Hyogo Brain and Heart Center

10. Department of Cardiovascular Surgery, Nagasaki University Hospital

11. Department of Cardiology, The Sakakibara Heart Institute of Okayama

12. Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University

13. Department of Cardiology, Shizuoka City Shizuoka Hospital

14. Department of Cardiology, Kumamoto Saiseikai Hospital

15. Department of Cardiology, Miyazaki Medical Association Hospital Cardiovascular Center

16. Department of Cardiovascular Surgery, Graduate School of Medical Sciences, Kumamoto University

17. Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University

18. Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University

19. Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine

20. Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center

21. Primary Medical Science Department, Daiichi Sankyo Co., Ltd.

22. Data Intelligence Department, Daiichi Sankyo Co., Ltd.

23. Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-21-0564/_pdf

Reference23 articles.

1. 1. Hollenberg SM. Valvular heart disease in adults: Etiologies, classification, and diagnosis. FP Essent 2017; 457: 11–16.

2. 2. Ray S. Changing epidemiology and natural history of valvular heart disease. Clin Med (Lond) 2010; 10: 168–171.

3. 3. Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery, Shimizu H, Endo S, Natsugoe S, Doki Y, Hirata Y, Kobayashi J, et al. Thoracic and cardiovascular surgery in Japan in 2016: Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 2019; 67: 377–411.

4. 4. Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I, et al. Prevalence of atrial fibrillation in the general population of Japan: An analysis based on periodic health examination. Int J Cardiol 2009; 137: 102–107.

5. 5. January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons. Circulation 2019; 140: e125–e151.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical effects of direct oral anticoagulants in elderly patients with a bioprosthetic valve and atrial fibrillation;International Journal of Cardiology;2024-10

2. R2-CHA2DS2-VASc Score for Cardiovascular Event Prediction After Bioprosthetic Valve Replacement　― Subanalysis From the BPV-AF Registry ―;Circulation Reports;2024-08-09

3. Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early After Surgical Bioprosthetic Valve Replacement: Rationale and Design of the ENBALV Trial;Cardiovascular Drugs and Therapy;2024-06-24

4. Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early After Surgical Bioprosthetic Valve Replacement: Rationale and Design of the Enbalv Trial;2024-01-22

5. An Evidence-Based Approach to Anticoagulation Therapy Comparing Direct Oral Anticoagulants and Vitamin K Antagonists in Patients With Atrial Fibrillation and Bioprosthetic Valves: A Systematic Review, Meta-Analysis, and Network Meta-Analysis;The American Journal of Cardiology;2023-11